|
Market Closed -
Euronext Paris
11:55:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.0626 EUR | -0.63% |
|
-0.63% | +23.23% |
| 03-30 | Neolife SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-09-29 | Neolife SA Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
Company Valuation: Neolife
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Market Cap 1 | 6.866 | 23.36 | 16.13 | 3.687 | 6.929 |
| Change | - | 240.27% | -30.95% | -77.14% | 87.91% |
| Enterprise Value (EV) 1 | 7.143 | 23.31 | 17 | 4.341 | 7.35 |
| Change | - | 226.3% | -27.07% | -74.46% | 69.33% |
| P/E | -8.1x | -45.2x | -95.3x | -1.87x | -13.2x |
| PBR | 3.27x | 10.9x | 7.24x | 1.41x | 1.61x |
| PEG | - | 0.9x | 1.4x | -0x | 0.2x |
| Capitalization / Revenue | 0.79x | 2.88x | 1.46x | 0.27x | 0.52x |
| EV / Revenue | 0.83x | 2.87x | 1.53x | 0.32x | 0.55x |
| EV / EBITDA | -15.6x | 68.8x | 118x | -4.85x | 49.3x |
| EV / EBIT | -11.3x | -68.3x | 1,953x | -4.21x | -13.9x |
| EV / FCF | -18.3x | 55.1x | -15.6x | -7.71x | - |
| FCF Yield | -5.47% | 1.82% | -6.41% | -13% | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.02 | -0.01 | -0.003233 | -0.0376 | -0.005432 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 8.655 | 8.126 | 11.09 | 13.55 | 13.43 |
| EBITDA 1 | -0.4572 | 0.3389 | 0.1444 | -0.8945 | 0.1491 |
| EBIT 1 | -0.6331 | -0.3414 | 0.008702 | -1.03 | -0.5289 |
| Net income 1 | -0.9307 | -0.5163 | -0.1693 | -3.625 | -0.5235 |
| Net Debt 1 | 0.2768 | -0.0553 | 0.8645 | 0.6534 | 0.4211 |
| Reference price 2 | 0.1620 | 0.4520 | 0.3080 | 0.0704 | 0.0719 |
| Nbr of stocks (in thousands) | 42,382 | 51,687 | 52,378 | 52,378 | 96,371 |
| Announcement Date | 6/25/20 | 4/5/22 | 4/5/22 | 4/28/23 | 4/29/24 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 6.92M | ||
| 14.61x | 1.76x | 8.47x | 1.85% | 56.58B | ||
| 31.13x | 5.83x | 17.23x | 0.71% | 34.39B | ||
| 33.42x | 3.46x | 17.74x | 0.92% | 34.24B | ||
| 27.31x | 4.33x | 14.46x | 0.85% | 31.75B | ||
| 11.43x | 1.38x | 6.41x | 2.69% | 28.78B | ||
| 22.08x | 6.87x | 13.53x | 1.97% | 25.46B | ||
| 72.99x | 4.55x | 70.45x | 0.31% | 22.58B | ||
| 15.52x | 1.95x | 7.83x | 1.41% | 20.71B | ||
| 10.1x | 1.11x | 5.43x | 1.02% | 14.15B | ||
| Average | 26.51x | 3.47x | 17.95x | 1.3% | 26.86B | |
| Weighted average by Cap. | 25.73x | 3.46x | 16.74x | 1.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALNLF Stock
- Valuation Neolife
Select your edition
All financial news and data tailored to specific country editions
















